Issue link: https://beckershealthcare.uberflip.com/i/1518468
18 DEVICES & IMPLANTS Stryker, Zimmer Biomet, J&J execs among the most 'influential' in healthcare By Carly Behm C EOWorld Magazine released its latest list of "World's Most Influential CEOs and Business Executives," and three orthopedic devicemaker leaders are on it. e magazine evaluated more than 2,300 CEOs at large public companies across 61 countries. Rankings weighed factors including financial returns and the company's track record on environmental, governance and social issues. Read more about the methodology here. Here are three orthopedic medtech leaders making the list and their overall ranking: 32. Joaquin Duato, Johnson & Johnson. Mr. Duato became CEO of Johnson & Johnson aer the company split into two companies. He was paid $13.1 million in 2022. 344. Kevin Lobo, Stryker. Mr. Lobo has been CEO of Stryker since 2012. He first started working at Stryker in 2011 and was group president of orthopedics before he was promoted to CEO. In 2014, he was named chair of the board. 1,245. Christopher Begley, Zimmer Biomet. Mr. Begley is chair of the board at Zimmer Biomet. He is a retired executive chair and CEO of Hospira Inc. n ZimVie to sell spine business for $375M By Carly Behm ZimVie is selling its spine business to HIG Capital for $375 million. e devicemaker's core spine, motion preservation and EBI bone healing portfolios will be sold off to "create a leaner, more focused ZimVie with a leading position in attractive and growing global dental markets," CEO Vafa Jamali said in a Dec. 18 news release. ZimVie's stock shares rose 40% early Dec. 18 amid news of the sale, Seeking Alpha reported. e transaction is expected to close in the first half of 2024. Zimmer Biomet's spine and dental businesses split off through ZimVie in 2022. In 2023, ZimVie's spine sales saw year-over-year sales decreases in the first, second and third quarters. n Augmedics CEO exits, interim leadership named By Carly Behm Kevin Hykes stepped down as president and CEO of Augmedics, the company said Jan. 31. Mr. Hykes left the company to "pursue other professional opportunities," according to a news release. Rick Anderson, the company's board chair will oversee interim leadership. Mr. Hykes joined Augmedics in January 2022 and oversaw milestones including the company's first artificial intelligence application, the acquisition of Surgalign's digital health business and an $82 million Series D financing. During his tenure Augmedics also reached its 5,000th augmented reality-assisted spine surgery. This is the second time since 2022 that Augmedics shuffled its leadership. In 2022 the company's founder, Nissan Elimelech, stepped down as CEO. When he left, Mr. Hykes took his place. n NuVasive lays off 157 after merger By Carly Behm N uVasive is laying off 157 employees at its San Diego headquarters, according to WARN notice data from the state of California. The permanent layoffs go into effect March 3, according to WARN data from the state. Globus Medical and NuVasive merged in September last year. The deal valued NuVasive at $3.1 billion. NuVasive confirmed "organizational restructuring across the combined company" to Becker's in a Jan. 26 email. Globus Medical didn't immediately respond to a request for comment. This article will be updated if they do. n